Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing
Phase 3
- Conditions
- Malignant Tumor
- Registration Number
- JPRN-jRCT2031210487
- Lead Sponsor
- Kawai Norisuke
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 262
Inclusion Criteria
Inclusion Criteria:
1.Any participant who is receiving study treatment and deriving significant clinical benefit or is in the safety and/or survival follow-up period in a Pfizer-sponsored Avelumab Parent Study.
2.Participants must agree to follow the reproductive criteria.
3.Participants must be willing and able to comply with all scheduled visits, treatment plan, and other study procedures.
Exclusion Criteria
Exclusion Criteria:
1.Female participants who are pregnant or breastfeeding.
2.Any medical reason that, in the opinion of the Investigator or Sponsor, precludes the participant from inclusion in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method